Avandia Drug Maker Agrees to Pay $3 Billion Settlement

Ennis & Ennis, P.A. explains the potential “Big Pharma” settlement. (PRWEB) November 06, 2011 British pharmaceutical company, GlaxoSmithKline (GSK), agreed to pay the US government $3 billion to settle criminal and civil investigations, reports Ennis & Ennis, P.A. If approved, the federal settlement will be the largest settlement for GSK, which is accused of illegally pushing its drugs. The claims against GSK include illegal marketing of Avandia, a type 2 diabetes medication. Company whistle-blowers and federal prosecutors said the company had paid doctors and manipulated medica
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations